---
title: systematic-Treatment
---
# systematic-Treatment

The poor risk model used in the global ARCC trial to direct treatment with temsirolimus included at least 3 of the following 6 predictors of short survival: 
* <1 year from the time of diagnosis to start of systemic therapy, 
* Karnofsky performance status score 60â€“70, 
* hemoglobin <LLN, 
* corrected calcium >10 mg/dL, 
* LDH >1.5 times the ULN, 
* and metastasis in multiple organs. 
Hudes G, et al. N Engl J Med 2007;356:2271-2281.
